Coronavirus Treatment Drugs Market Players Merck and Ridgeback Biotherapeutics Report Development of Covid-19 Drug
The pandemic of COVID-19 continues to expand and impact over 175 countries and territories worldwide, which is expected to propel growth of the coronavirus treatment drugs market. Globally, as of 10:16am CET, 10 March 2021, there have been 117,132,788 confirmed cases of COVID-19, including 2,600,839 deaths, as reported to the World Health Organization. As of 9 March 2021, a total of 268,205,245 vaccine doses have been administered. As the COVID-19 vaccine rolls out across the world, a new drug has come forward to help fight the pandemic. Prominent players in the coronavirus treatment drugs market Merck and Ridgeback Biotherapeutics reported development of the drug, molnupiravir for the treatment of Covid-19. Both the companies reported that the drug, in a recent phase 2 trial reduced the severity of the flu. The Middle East is expected to witness significant growth in the coronavirus treatment drugs market due to several R&D activities. In February 2021, Tel Aviv’s Ichi...